Home›Search›Cancer Innovation

Cancer Innovation

John Wiley and Sons Inc · United States · Est. 1932

ISSN2770-9191eISSN2770-9183

SJR Q1✓ WOS ESCI✓ Scopus / SJR✓ DOAJ✓ Open Access

100

/ 100

High Trust

PubScope credibility score from verifiable indexing & ethics signals

Score Breakdown

◆ Scopus Q178

✓ Corroboration (4 more)+22

Total100

Level data: Norwegian Register (HK-dir), NLOD 2.0. · Third-party records · how this is calculated · Report an error →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

192

days submission → published

measured · last 16 articles · accept 130d

weeks to publish · journal-reported

Average · vs ~15 wk median

SJR Rank

Top 25% in field

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (ESCI) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q1. Source: Clarivate Journal Citation Reports.

SJR Scorei

0.921

H-Indexi

CiteScore

View ↗

Scopus metric · on the journal’s page

Total Worksi

246

Total Citationsi

1,139

2yr Mean Citednessi

2.68

Open Impact Factor alternative

Aims & Scope

Subject areas: Oncology; Pharmacology, Toxicology and Pharmaceutics (miscellaneous); Drug Discovery; Pharmacology (medical); Cancer Research.

General Information

Country / RegionUnited States

Primary LanguageEnglish

1st Year Published1932

FrequencySix Issues A Year

StatusActive (last: 2026)

Total Publications246

Publisher OrgWiley

OA Since2021

Visit Journal Website

Submission Info

Peer ReviewSingle-blind

Review Time~12 weeks

Acceptance Rate—

OA LicenseCC BY, CC BY-NC, CC BY-NC-ND

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Plagiarism Detection✓ Yes

📦 Long-term Preservation

PorticoPMCCLOCKSS

Think.Check.Submit Compliance

thinkchecksubmit.org

10/12 · 83%

✅

Do you know the journal / publisher?

John Wiley and Sons Inc

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

2770-9191 / 2770-9183

✅

Indexed in a trusted database?

WoS, Scopus, DOAJ, PubMed

✅

Peer review process documented?

Single-blind

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

✅

Long-term digital preservation?

Portico, PMC, CLOCKSS

✅

Plagiarism detection in place?

Yes

✅

Listed in DOAJ (verified OA)?

DOAJ verified

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Pharmacology, Toxicology and Pharmaceutics (miscellaneous)Q1

Drug DiscoveryQ2

OncologyQ2

Pharmacology (medical)Q2

Cancer ResearchQ3

Subject Classification

Web of Science Categories

Oncology

Scopus Categories

Pharmacology (medical)Drug DiscoveryCancer ResearchOncologyPharmacology, Toxicology and Pharmaceutics (miscellaneous)

Research Topics (OpenAlex)

Cancer Immunotherapy and BiomarkersBreast Cancer Treatment StudiesFerroptosis and cancer prognosisDiverse Scientific and Economic StudiesHuman auditory perception and evaluationEducational Robotics and EngineeringHER2/EGFR in Cancer ResearchLung Cancer Research StudiesRadiomics and Machine Learning in Medical ImagingAdvanced Breast Cancer Therapies

Frequently asked questions about Cancer Innovation

Is Cancer Innovation a predatory journal?

PubScope has no integrity flags on record for Cancer Innovation: it is indexed in Web of Science, Scopus, DOAJ, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 100/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Cancer Innovation?

Cancer Innovation is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 2.68.

Is Cancer Innovation indexed in Scopus and Web of Science?

Cancer Innovation is indexed in Web of Science, Scopus, DOAJ.

What is the aims and scope of Cancer Innovation?